Literature DB >> 34150066

Effects of comprehensive care in patients with multiple myeloma with cardiac dysfunction.

Jinglu Xu1, Ru Bai2.   

Abstract

OBJECTIVE: To explore the effect of comprehensive care on cardiac and renal function indices, treatment compliance, self-care ability and quality of life in patients with multiple myeloma combined with cardiac dysfunction.
METHODS: A total of 53 patients diagnosed with multiple myeloma combined with cardiac dysfunction admitted to our hospital were enrolled and divided into the control group (n=25) and the experimental group (n=28) by the method of random number table. Patients in the control group were given routine nursing care, while patients in the experimental group were given comprehensive care on the basis of the routine nursing care of the control group. The changes in cardiac and renal function indices, treatment compliance, self-care ability, and quality of life were observed after intervention of different nursing methods in the two groups.
RESULTS: The levels of left ventricular ejection fraction, brain natriuretic peptide, N-terminal pro-brain natriuretic peptide, glomerular filtration rate, serum creatinine, and uric acid in the experimental group were significantly improved after intervention, showing significant differences between the two groups (P<0.05). The treatment compliance in the experimental group (92.86%) was significantly higher than that in the control group (68%). The scores of self-care ability and quality of life in the experimental group were significantly higher than those in the control group after intervention (P<0.05).
CONCLUSION: Comprehensive care can significantly help to improve cardiac and renal functions, treatment compliance, self-care ability and quality of life in patients with multiple myeloma combined with cardiac dysfunction, which is of great clinical significance. AJTR
Copyright © 2021.

Entities:  

Keywords:  Multiple myeloma; quality of life; renal function; self-care ability; treatment compliance

Year:  2021        PMID: 34150066      PMCID: PMC8205761     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  28 in total

1.  Survivorship care guidelines for patients living with multiple myeloma: consensus statements of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Elizabeth Bilotti; Beth M Faiman; Tiffany A Richards; Joseph D Tariman; Teresa S Miceli; Sandra I Rome
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

Review 2.  Panobinostat for the management of multiple myeloma.

Authors:  Dharshan Sivaraj; Michael M Green; Cristina Gasparetto
Journal:  Future Oncol       Date:  2016-10-25       Impact factor: 3.404

3.  Factors influencing quality of life in patients with multiple myeloma.

Authors:  Hee-Young Kang; Eun-Young Choi
Journal:  Contemp Nurse       Date:  2019-05-30       Impact factor: 1.787

Review 4.  Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes.

Authors:  O Landgren; K Iskander
Journal:  J Intern Med       Date:  2017-02-16       Impact factor: 8.989

5.  Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study.

Authors:  Kristin D Kistler; Jill Kalman; Gagan Sahni; Brian Murphy; Winifred Werther; Kanya Rajangam; Ajai Chari
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-11-22

6.  Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure.

Authors:  Fan Zhou; Chenhui Ling; Lieping Guo; Wei Wei; Lu Li; Haotian Shi; Jian Hou
Journal:  Leuk Lymphoma       Date:  2014-03-17

7.  Echocardiography-Defined Pulmonary Hypertension in Multiple Myeloma: Risk Factors and Impact on Outcomes.

Authors:  Rahul G Sangani; Matthew Butler; H Lester Kirchner; Andrea Berger; Jason A Stamm
Journal:  South Med J       Date:  2016-05       Impact factor: 0.954

Review 8.  Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.

Authors:  R A Kyle; S V Rajkumar
Journal:  Leukemia       Date:  2008-10-30       Impact factor: 11.528

Review 9.  Multiple Myeloma: Diagnosis and Treatment.

Authors:  S Vincent Rajkumar; Shaji Kumar
Journal:  Mayo Clin Proc       Date:  2016-01       Impact factor: 7.616

10.  Living with relapsed myeloma: Symptoms and self-care strategies.

Authors:  Orlaith Cormican; Maura Dowling
Journal:  J Clin Nurs       Date:  2018-03-15       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.